{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:29:10Z","timestamp":1792895350848,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:00:00Z","timestamp":1397606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jhep.2014.04.012","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T18:39:56Z","timestamp":1397846396000},"page":"396-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":532,"title":["Human serum albumin, systemic inflammation, and cirrhosis"],"prefix":"10.1016","volume":"61","author":[{"given":"Vicente","family":"Arroyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Garc\u00eda-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Salvatella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.04.012_b0005","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0010","series-title":"All about albumin. Biochemistry and medical applications","author":"Peters","year":"1966"},{"key":"10.1016\/j.jhep.2014.04.012_b0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1172\/JCI101711","article-title":"Chemical, clinical, and immunological studies on the products of human plasma fractionation. XXXI. The use of salt-poor concentrated human serum albumin solution in the treatment of hepatic cirrhosis","volume":"25","author":"Thorn","year":"1946","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.04.012_b0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1172\/JCI101959","article-title":"The use of concentrated human serum albumin in the treatment of cirrhosis of the liver","volume":"27","author":"Kunkel","year":"1948","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.04.012_b0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI102108","article-title":"An evaluation of human serum albumin in the treatment of cirrhosis of the liver","volume":"28","author":"Faloon","year":"1949","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.04.012_b0030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(56)90149-0","article-title":"Electrolyte and circulatory changes in terminal liver failure","volume":"271","author":"Hecker","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2014.04.012_b0035","first-page":"17","article-title":"Intravenous albumin loading in ascitic cirrhosis. Biological study","volume":"40","author":"Traverso","year":"1964","journal-title":"Sem Hop"},{"key":"10.1016\/j.jhep.2014.04.012_b0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archsurg.1978.01370170043006","article-title":"Renal failure in ascites secondary to hepatic, renal, and pancreatic disease. Treatment with a LeVeen peritoneovenous shunt","volume":"113","author":"Wapnick","year":"1978","journal-title":"Arch Surg"},{"key":"10.1016\/j.jhep.2014.04.012_b0045","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0016-5085(87)91007-9","article-title":"Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study","volume":"93","author":"Gin\u00e8s","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0050","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0016-5085(90)91303-N","article-title":"Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites","volume":"98","author":"Tit\u00f3","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0168-8278(94)80116-9","article-title":"A European survey on the treatment of ascites in cirrhosis","volume":"21","author":"Arroyo","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0060","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJM199109193251201","article-title":"Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites","volume":"325","author":"Gin\u00e8s","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.04.012_b0065","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0070","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/0016-5085(90)90481-F","article-title":"Dextran-70 vs. albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study","volume":"99","author":"Planas","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0075","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gin\u00e8s","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0080","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0168-8278(97)80081-5","article-title":"Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis","volume":"27","author":"Sal\u00f3","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0085","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","article-title":"Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis","volume":"113","author":"Ruiz-del-Arbol","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0090","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(98)80288-2","article-title":"Hemodynamic changes in patients developing effective hypovolemia after total paracentesis","volume":"28","author":"Vila","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0095","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0100","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0105","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0115","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0120","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0125","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2011.11.023","article-title":"Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study","volume":"56","author":"Pereira","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0130","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/0016-5085(93)90361-F","article-title":"Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients","volume":"104","author":"Byl","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jhep.2003.11.017","article-title":"High-density lipoproteins reduce the effect of endotoxin on cytokine production and systemic hemodynamics in cirrhotic rats with ascites","volume":"40","author":"Ram\u00edrez","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0140","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0150","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fern\u00e1ndez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.04.012_b0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0165","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ki.1985.142","article-title":"Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients","volume":"28","author":"Shapiro","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2014.04.012_b0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","article-title":"Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion","volume":"27","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0180","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites","volume":"350","author":"Gin\u00e8s","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.04.012_b0185","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/ajg.2009.191","volume":"104","author":"Garcia-Tsao","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.04.012_b0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"Gin\u00e8s","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0195","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0168-8278(09)60177-X","article-title":"Terlipressin given as continuous intravenous infusion vs. terlipressin given as intravenous boluses in the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis","volume":"50","author":"Angeli","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0200","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0205","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.ajkd.2011.07.017","article-title":"Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials","volume":"58","author":"Velez","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2014.04.012_b0210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0215","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0220","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrneph.2011.96","article-title":"Management of hepatorenal syndrome in patients with cirrhosis","volume":"7","author":"Arroyo","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jhep.2014.04.012_b0225","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs. terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0230","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline vs. terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.04.012_b0235","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0240","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0245","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs. albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0250","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0255","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1111\/j.1572-0241.2005.00271.x","article-title":"Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study","volume":"100","author":"P\u00e9ron","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.04.012_b0260","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","article-title":"Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis","volume":"60","author":"Rodr\u00edguez","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0265","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","article-title":"Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2","volume":"14","author":"Alessandria","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0270","first-page":"71","article-title":"Influence of long-term administration of serum albumin on the prognosis of liver cirrhosis in man","volume":"8","author":"Tarao","year":"1983","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1016\/j.jhep.2014.04.012_b0275","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(99)80194-9","article-title":"Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial","volume":"30","author":"Gentilini","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0280","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0285","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.04.012_b0290","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","article-title":"Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival","volume":"59","author":"Oettl","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0295","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.bbagen.2013.04.036","article-title":"Redox properties of serum albumin","volume":"1830","author":"Anraku","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.012_b0300","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1126\/science.2727704","article-title":"Three-dimensional structure of human serum albumin","volume":"244","author":"Carter","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.04.012_b0305","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1006\/jmbi.2000.4158","article-title":"Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to HSA","volume":"303","author":"Bhattacharya","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jhep.2014.04.012_b0310","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/prep.2000.1330","article-title":"Expression, refolding, and isotopic labeling of human serum albumin domains for NMR spectroscopy","volume":"20","author":"Mao","year":"2000","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.jhep.2014.04.012_b0315","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bpj.2010.11.037","article-title":"Stoichiometry and affinity of the human serum albumin-Alzheimer\u2019s A\u03b2 peptide interactions","volume":"100","author":"Milojevic","year":"2011","journal-title":"Biophys J"},{"key":"10.1016\/j.jhep.2014.04.012_b0320","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1432-1033.1989.tb14564.x","article-title":"Refolding human serum albumin at relatively high protein concentration","volume":"179","author":"Burton","year":"1989","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jhep.2014.04.012_b0325","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1016\/j.bbagen.2013.04.037","article-title":"Human serum albumin from recombinant DNA technology: challenges and strategies","volume":"1830","author":"Chen","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.012_b0330","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0021-9258(19)45590-7","article-title":"Conformational changes in human serum albumin as revealed by hydrogen-deuterium exchange studies","volume":"247","author":"Hvidt","year":"1972","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0335","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1006\/jmbi.2000.4158","article-title":"Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin","volume":"303","author":"Bhattacharya","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jhep.2014.04.012_b0340","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jhep.2014.04.012_b0345","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1016\/j.bbagen.2013.05.005","article-title":"Albumin-drug interaction and its clinical implication","volume":"1830","author":"Yamasaki","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.012_b0350","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1111\/j.1742-4658.2009.06952.x","article-title":"Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin \u2013 an optical and NMR spectroscopic investigation","volume":"276","author":"Fanali","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.jhep.2014.04.012_b0355","doi-asserted-by":"crossref","first-page":"39675","DOI":"10.1074\/jbc.R111.278929","article-title":"Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors","volume":"286","author":"Hilser","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0360","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0365","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1016\/j.bbagen.2013.05.010","article-title":"Glycated albumin and diabetes mellitus","volume":"1830","author":"Furusyo","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.012_b0370","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1111\/j.1742-4658.2006.05341.x","article-title":"Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions","volume":"273","author":"Kawakami","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.jhep.2014.04.012_b0375","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1016\/S0021-9258(17)37571-3","article-title":"Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins","volume":"269","author":"Schnitzer","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0380","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00418-001-0367-x","article-title":"Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function","volume":"117","author":"Minshall","year":"2002","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.jhep.2014.04.012_b0385","first-page":"13","article-title":"Targeting endothelial cell surface receptors: novel mechanisms of microvascular endothelial barrier transport","volume":"2","author":"Malik","year":"2009","journal-title":"J Med Sci"},{"key":"10.1016\/j.jhep.2014.04.012_b0390","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.bbagen.2013.04.023","article-title":"Albumin as a versatile platform for drug half-life extension","volume":"1830","author":"Sleep","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.012_b0395","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.107.1.231","article-title":"Identification of albumin-binding proteins in capillary endothelial cells","volume":"107","author":"Ghinea","year":"1988","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jhep.2014.04.012_b0400","doi-asserted-by":"crossref","first-page":"24544","DOI":"10.1016\/S0021-9258(18)35799-5","article-title":"Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism","volume":"267","author":"Schnitzer","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0405","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1016\/S0021-9258(18)53212-9","article-title":"High affinity binding, endocytosis, and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors","volume":"268","author":"Schnitzer","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0410","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1074\/jbc.M109.081828","article-title":"Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding","volume":"285","author":"Andersen","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0415","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1074\/jbc.M110.164848","article-title":"Extending half-life by indirect targeting of the neonatal Fc receptor (FcRn) using a minimal albumin binding domain","volume":"286","author":"Andersen","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0420","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1021\/bc010003g","article-title":"Prolonged in vivo residence times of antibody fragments associated with albumin","volume":"12","author":"Smith","year":"2001","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0425","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1016\/j.bbagen.2013.03.032","article-title":"Fatty acid binding to serum albumin: molecular simulation approaches","volume":"1830","author":"Fujiwara","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.012_b0430","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2133\/dmpk.24.300","article-title":"Albumin as fatty acid transporter","volume":"24","author":"Van der Vusse","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jhep.2014.04.012_b0435","doi-asserted-by":"crossref","first-page":"20985","DOI":"10.1074\/jbc.M001038200","article-title":"A dynamic model for bilirubin binding to human serum albumin","volume":"275","author":"Petersen","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0440","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1016\/j.bbagen.2013.04.012","article-title":"Novel insights into the pleiotropic effects of human serum albumin in health and disease","volume":"1830","author":"Ha","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.012_b0445","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1016\/j.bbagen.2013.06.032","article-title":"Structural studies of several clinically important oncology drugs in complex with human serum albumin","volume":"1830","author":"Wang","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.012_b0450","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/ndt\/gfr616","article-title":"Albumin-binding capacity (ABiC) is reduced in patients with chronic kidney disease along with an accumulation of protein-bound uraemic toxins","volume":"27","author":"Klammt","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2014.04.012_b0455","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MEG.0b013e3280101f7d","article-title":"Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease","volume":"19","author":"Klammt","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0460","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jhep.2014.04.012_b0465","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","article-title":"The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery","volume":"9","author":"Smith","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2014.04.012_b0470","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/09680519020080020501","article-title":"Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A","volume":"8","author":"Jurgens","year":"2002","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.jhep.2014.04.012_b0475","doi-asserted-by":"crossref","first-page":"172S","DOI":"10.1097\/01.alc.0000189278.30237.e9","article-title":"Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure","volume":"29","author":"Fukui","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2014.04.012_b0480","doi-asserted-by":"crossref","first-page":"20431","DOI":"10.1016\/S0021-9258(17)32010-0","article-title":"Cell-bound albumin is the 70-kDa peptidoglycan-, lipopolysaccharide-, and lipoteichoic acid-binding protein on lymphocytes and macrophages","volume":"269","author":"Dziarski","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0485","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/096805199500200204","article-title":"Characterization of the interaction of lipid A and lipopolysaccharide with human serum albumin: implications for an endotoxin carrier function for albumin","volume":"2","author":"David","year":"1995","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.jhep.2014.04.012_b0490","doi-asserted-by":"crossref","first-page":"47818","DOI":"10.1074\/jbc.M206404200","article-title":"An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation","volume":"277","author":"Gioannini","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0495","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-9255-8-4","article-title":"Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells","volume":"8","author":"Blomkalns","year":"2011","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.jhep.2014.04.012_b0500","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/1753425911422723","article-title":"Endotoxin{middle dot}albumin complexes transfer endotoxin monomers to MD-2 resulting in activation of TLR4","volume":"18","author":"Esparza","year":"2012","journal-title":"Innate Immun"},{"key":"10.1016\/j.jhep.2014.04.012_b0505","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2014.04.012_b0510","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI62423","article-title":"Alarmins: awaiting a clinical response","volume":"122","author":"Chan","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.04.012_b0515","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/viru.26907","article-title":"The role of mitochondrial dysfunction in sepsis-induced multi-organ failure","volume":"5","author":"Singer","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.jhep.2014.04.012_b0520","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/bja\/aer093","article-title":"Oxidative stress and mitochondrial dysfunction in sepsis","volume":"107","author":"Galley","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jhep.2014.04.012_b0525","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/cc9098","article-title":"Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis","volume":"14","author":"Galley","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.jhep.2014.04.012_b0530","first-page":"4","article-title":"Specific antioxidant properties of human serum albumin","volume":"3","author":"Taverna","year":"2013","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jhep.2014.04.012_b0535","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1016\/j.bbagen.2013.04.017","article-title":"Oxidized albumin. The long way of a protein of uncertain function","volume":"1830","author":"Bruschi","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.012_b0540","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1164\/ajrccm.162.4.9910106","article-title":"Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation","volume":"162","author":"Cantin","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jhep.2014.04.012_b0545","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1016\/j.bbagen.2013.06.018","article-title":"Binding of transition metal ions to albumin: sites, affinities and rates","volume":"1830","author":"Bal","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.012_b0550","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0891-5849(94)00159-H","article-title":"Oxidative mechanisms in the toxicity of metal ions","volume":"18","author":"Stohs","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2014.04.012_b0555","doi-asserted-by":"crossref","first-page":"16712","DOI":"10.1016\/S0021-9258(19)89449-8","article-title":"Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation","volume":"269","author":"Neuzil","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0560","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10715760400024935","article-title":"Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin","volume":"39","author":"Bourdon","year":"2005","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jhep.2014.04.012_b0565","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1074\/jbc.272.33.20313","article-title":"Protein oxidation in aging, disease, and oxidative stress","volume":"272","author":"Berlett","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0570","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0076-6879(10)74011-8","article-title":"Redox state of human serum albumin in terms of cysteine-34 in health and disease","volume":"474","author":"Oettl","year":"2010","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jhep.2014.04.012_b0575","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1073\/pnas.092048999","article-title":"Catalysis of S-nitrosothiols formation by serum albumin: the mechanism and implication in vascular control","volume":"99","author":"Rafikova","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.04.012_b0580","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/S0021-9258(17)43205-4","article-title":"Albumin-eicosanoid interactions. A model system to determine their attributes and inhibition","volume":"259","author":"Fitzpatrick","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.012_b0585","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1016\/j.bbagen.2013.03.015","article-title":"Molecular and practical aspects of the enzymatic properties of human serum albumin and of albumin-ligand complexes","volume":"1830","author":"Kragh-Hansen","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.012_b0590","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1110\/ps.28702","article-title":"Structural insights into human serum albumin-mediated prostaglandin catalysis","volume":"11","author":"Yang","year":"2002","journal-title":"Protein Sci"},{"key":"10.1016\/j.jhep.2014.04.012_b0595","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0090-6980(80)90138-0","article-title":"Albumins stabilize prostaglandin I2","volume":"20","author":"Wynalda","year":"1980","journal-title":"Prostaglandins"},{"key":"10.1016\/j.jhep.2014.04.012_b0600","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-5793(77)80611-X","article-title":"Albumin stabilizes thromboxane A2","volume":"82","author":"Folco","year":"1977","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhep.2014.04.012_b0605","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0168-8278(95)80196-0","article-title":"Plasma endotoxin and tumor necrosis factor-alpha in the hyperkinetic state of cirrhosis","volume":"23","author":"Le Moine","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0610","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0676.1995.tb00683.x","article-title":"High interleukin-6 production within the peritoneal cavity in decompensated cirrhosis and malignancy-related ascites","volume":"15","author":"Bac","year":"1995","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2014.04.012_b0615","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1478-3231.2004.0894.x","article-title":"Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure","volume":"24","author":"Odeh","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2014.04.012_b0620","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3109\/00365529609006772","article-title":"Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation","volume":"31","author":"Lee","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.04.012_b0625","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1440-1746.1996.tb00306.x","article-title":"Plasma interleukin-8 levels in patients with post-hepatitic cirrhosis: relationship to severity of liver disease, portal hypertension and hyperdynamic circulation","volume":"11","author":"Li","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0630","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0016-5085(92)91122-K","article-title":"Serum levels of cytokines in chronic liver diseases","volume":"103","author":"Tilg","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.012_b0635","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1572-0241.1999.00790.x","article-title":"Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis","volume":"94","author":"Genesca","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.04.012_b0640","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.dld.2012.07.002","article-title":"Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy","volume":"44","author":"Jain","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2014.04.012_b0645","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31815e7f58","article-title":"IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy","volume":"43","author":"Montoliu","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2014.04.012_b0650","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0655","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0660","first-page":"102","article-title":"Role of sympathetic nervous activity for bacterial translocation in advanced experimental liver cirrhosis","volume":"34","author":"Wiest","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0665","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI7458","article-title":"Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility","volume":"104","author":"Wiest","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.04.012_b0670","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0675","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0680","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"S M\u00f8ller2. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.04.012_b0685","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","article-title":"Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms","volume":"57","author":"Bortoluzzi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0690","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","article-title":"A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury","volume":"41","author":"Gomez","year":"2014","journal-title":"Shock"},{"key":"10.1016\/j.jhep.2014.04.012_b0695","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/CIRCULATIONAHA.106.678359","article-title":"Sepsis and the heart","volume":"116","author":"Merx","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2014.04.012_b0700","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.abb.2013.03.016","article-title":"Inflammation and hepatic encephalopathy","volume":"536","author":"Coltart","year":"2013","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jhep.2014.04.012_b0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-012-9370-2","article-title":"Systemic inflammation and ammonia in hepatic encephalopathy","volume":"28","author":"Tranah","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2014.04.012_b0710","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.3748\/wjg.v16.i27.3347","article-title":"Changing face of hepatic encephalopathy: role of inflammation and oxidative stress","volume":"16","author":"Seyan","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.04.012_b0715","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/jcbfm.2011.48","article-title":"Neuro-oxidative-nitrosative stress in sepsis","volume":"31","author":"Berg","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jhep.2014.04.012_b0720","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jhep.2011.11.003","article-title":"Liver-induced inflammation hurts the brain","volume":"56","author":"Garcia-Martinez","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0725","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.510280107","article-title":"Increased cerebrovascular resistance in cirrhotic patients with ascites","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0730","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/hep.21599","article-title":"Endotoxemia produces coma and brain swelling in bile duct ligated rats","volume":"45","author":"Wright","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0735","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2003.10.016","article-title":"Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis","volume":"40","author":"Shawcross","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0740","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jhep.2010.07.045","article-title":"Infection and systemic inflammation, not ammonia, are associated with Grade 3\/4 hepatic encephalopathy, but not mortality in cirrhosis","volume":"54","author":"Shawcross","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0745","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","article-title":"Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)","volume":"60","author":"Cordoba","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0750","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2004.05.009","article-title":"Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"41","author":"Fern\u00e1ndez","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0755","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A randomized unblinded pilot study comparing alb\u00famina vs. hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fern\u00e1ndez","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0760","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.25806","article-title":"Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis","volume":"56","author":"Ferlitsch","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.012_b0765","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0168-8278(99)80104-4","article-title":"Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels","volume":"30","author":"Albornoz","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.012_b0770","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.510230613","article-title":"High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia","volume":"23","author":"Ferro","year":"1996","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814002657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814002657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T17:13:03Z","timestamp":1748279583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814002657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":154,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0168827814002657"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.04.012","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human serum albumin, systemic inflammation, and cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}